IMTX immatics.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Immatics N.V. (IMTX) is facing a liquidity shortage due to extensive R&D spending, necessitating external financing. The current EV/EBITDA multiple valuation demonstrates market resilience, where 0.00 shows the current value of the metric. This is supported by a staff of elite immunologists and the unique XPRESIDENT technology, which guarantees significant pricing power within the inelastic demand segment for cancer therapy.
Ringkesan rincian data analitis immatics.com (IMTX)
- rega saham lan target rega konsensus:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Immatics N.V.|IMTX - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Immatics|IMTX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Immatics Biotechnologies|IMTX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Immatics|Indikator likuiditas cepet immatics.com
- rincian asil keuangan lan kelipatan valuasi:
IMTX - Bathi resik taunan|Bathi mangsa ngarep Immatics N.V.|IMTX - Rasio rega pasar marang bathi resik|Pangali Forward P/E Immatics N.V.|IMTX - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Immatics Biotechnologies|IMTX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Immatics|IMTX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan immatics.com|IMTX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Immatics N.V.
Analisis fundamental perusahaan:IMTX (Immatics Corp)
Institutional investors are assessing the investment attractiveness of Immatics N.V. (IMTX), considering the risks of international clinical trial disruptions and patent disputes amid geopolitical instability. The current value of 0.00, reflected through the EV/EBITDA multiple, correlates the enterprise value (including net debt) to operating profit, allowing for a determination of the asset's premium relative to industry peers.
Analisis pesaing Immatics N.V.
ImmunityBio Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Immunocore Corp (IMCR) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|JANX: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai bisnis marang bathi operasional sadurunge panyusutan RCUS (arcusbio.com)|ZYME: Pangali EV/EBITDA|TNGX - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Iovance|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Xencor Inc. (XNCR)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Compass Therapeutics (CMPX)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan replimune.com REPL|Lyell Immunopharma, Inc. - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Pangali EV/EBITDA Innate Pharma SA IPHA|PYXS - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|CGEN (Compugen Ltd.) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|IO Biotech, Inc. (IOBT) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan sutrobio.com (STRO)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan INKT|HOWL - Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan IMMX (Immix Biopharma, Inc.)|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan ALXO|Pangali EV/EBITDA CUE (Cue Biopharma)|Nilai bisnis marang bathi operasional sadurunge panyusutan PDSB|Sonnet BioTherapeutics Holdings Inc. - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MAIA Biotech|Liminatus Pharma Corp (LIMN) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|LAVA Therapeutics - Nilai bisnis marang bathi operasional sadurunge panyusutan|NXTC (NextCure, Inc.) - Pangali EV/EBITDA|Pangali EV/EBITDA Leap Tx|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intensity Therapeutics (INTS)|SNSE: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan|Synthetic Biologics - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Gritstone bio Inc. (GRTS) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Kineta, Inc. - Pangali EV/EBITDA|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan neximmune.com NEXI|turnstonebio.com (TSBX) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vaccinex Inc.|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harpoon Tx
